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 2 
ABSTRACT  
 
Gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arises against a 
background of chronic inflammation caused by persistent Helicobacter pylori infection. 
The clinical and histopathological features of the human tumor can be reproduced by 
Helicobacter infection of BALB/c mice. In this study, we have analyzed the antibody 
sequences and antigen specificity of a panel of murine and human MALT lymphoma-
derived antibodies. We find that a majority of tumors in patients as well as 
experimentally infected mice are monoclonal. The tumor immunoglobulin heavy chain 
genes have undergone somatic hypermutation, and approximately half of all tumors show 
evidence of intraclonal variation and positive and/or negative selective pressure. 
Recombinantly expressed MALT lymphoma antibodies bind with intermediate affinity to 
various unrelated self and foreign antigens, including Helicobacter sonicate, IgG, DNA 
and stomach extract; antigen binding is blocked in a dose-dependent manner in 
competitive ELISAs. A strong bias towards the use of VH gene segments previously 
linked to auto- and/or polyreactive antibodies in B-cell malignancies or autoimmune 
pathologies supports the experimental finding of polyreactivity. Our results suggest that 
MALT lymphoma development may be facilitated by an array of local self and foreign 
antigens providing direct antigenic stimulation of the tumor cells via their B-cell receptor.  
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 3 
INTRODUCTION 
  
Gastric mucosa-associated lymphoid tissue (MALT) B-cell lymphoma develops in the 
context of long-term infection with the gram-negative gastric bacterium Helicobacter 
pylori.1-3 Persistent infection with H. pylori causes chronic gastritis which, in some 
individuals, can develop into more organized gastric mucosa-associated lymphoid tissue 
(MALT) with histological similarity to the Peyer’s patches of the small intestine.4 The 
disease progresses when individual malignant clones grow out, displace the benign 
lymphoid tissue and ultimately form the lympho-epithelial lesions that are a hallmark of 
MALT lymphoma.5,6 In its early stages, gastric MALT lymphoma is believed to be an 
antigen-dependent disease; H. pylori infection is detectable in a large majority of 
cases.1,3,7 Eradication therapy induces tumor regression in ~75% of patients at this 
stage.8,9 Early stage low grade MALT lymphoma is generally considered an indolent 
tumor due to its slow growth, low proliferation rates and minimal propensity for 
spreading. At later stages however, the tumors can eventually undergo high grade 
transformation or acquire one of several known characteristic chromosomal 
translocations, thereby rendering the lymphoma independent of antigen exposure and 
refractory to H. pylori eradication therapy.  
In contrast to cases with chromosomal rearrangements, which grow autonomously due to 
constitutive activation of the nuclear factor κB (NF-κB) signaling pathway brought about 
by over-expression of MALT-1, Bcl-10 or production of the API2-MALT1 fusion protein 
(reviewed in Isaacson and Du),5 little is known about the pathogenesis of early MALT 
lymphoma. Several studies have implicated the abundant population of tumor infiltrating 
T-cells in providing growth signals to tumor B-cells.10-12 In one study, depletion of T-
cells was shown to abrogate the proliferation of explanted MALT lymphoma cultures.12 
We and others have reported that MALT lymphomas express high levels of IL-4 and 
other Th2 cytokines in vivo, supporting a role for Th2-polarized T-helper responses in 
early MALT lymphomagenesis.10,11  
An alternative possibility is that early stage MALT lymphoma B-cells receive signals via 
antigenic stimulation through their B-cell receptor (BCR), which would lead to NF-κB 
activation, survival and proliferation. Indeed, MALT lymphoma cells carry functional, 
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 4 
rearranged and somatically mutated immunoglobulin genes on their surface.13,14 
Sequence analysis of the VH genes suggests that the tumor cells have undergone positive 
selection in germinal centers.14-16 Intraclonal variation caused by ongoing somatic 
mutation and/or replacement of a part of the variable heavy segment (receptor revision) 
has been reported.15-17 Despite these clear results, the search for a target antigen has 
proven to be difficult and has yielded controversial results, either providing evidence for 
reactivity towards certain structures of normal human tissues (follicular dendritic cells, 
venules, epithelial cells, connective tissue)18,19 or human IgG,13 or not identifying any 
target antigens at all.20  
We and others have shown earlier that long-term, persistent infection of the BALB/c 
strain of mice with Helicobacter pylori or its close relatives H. felis and H. heilmannii 
results in the reproducible induction of lesions that clinically and histologically resemble 
human MALT lymphoma.10,21-23 These lesions are slow-growing, spread only 
infrequently (usually to the spleen) and rarely transform to high grade lymphoma.10,22 
The tumors further recapitulate the human disease in that they regress in a majority of 
mice upon eradication of the infection,22 but recur rapidly upon re-introduction of the 
bacteria, revealing gastric persistence of the tumor clone despite complete histological 
remission.10 
Using this experimental mouse model as well as human MALT lymphoma biopsy 
material, we deduced and compared the immunoglobulin sequences of 20 murine and 7 
human tumors. Based on the monoclonal Ig sequences, we generated a comprehensive 
panel of recombinant antibodies expressed as soluble IgG of matching heavy and light 
chains, and tested their reactivity towards various self and foreign antigens. The tumor 
antibodies, which were functional and somatically hypermutated and in some cases 
showed evidence of positive and/or negative selection, surprisingly reacted with roughly 
equal affinity with both gastric self- and Helicobacter-derived foreign antigens. This 
pattern of reactivity is consistent with a diagnosis of polyreactivity, and could further be 
linked to a strongly biased use of specific VH family gene segments in both the murine 
and the human system.   
 
 
 For personal use only. at UNIVERSITAETSSPITAL on January 14, 2010. www.bloodjournal.orgFrom 
                                                   
   
 
 5 
MATERIALS AND METHODS  
 
Animal experimentation, tumor cell cultures and immunophenotyping 
Specific pathogen-free female BALB/c mice were infected orally at six weeks of age 
with three consecutive doses of ~5x107H. felis (CS1, ATCC 49179). All animal 
experiments were approved by Stanford University’s Institutional Animal Care and Use 
Committee. Upon sacrifice, the stomachs were removed and opened along the lesser 
curvature; macroscopically visible tumors were dissected. Single cell suspensions were 
generated and cultured in RPMI supplemented with 10% FCS and antibiotics. 10μg/ml 
Helicobacter lysate was where appropriate. Tumor cell proliferation was quantified by 
[3H]-thymidine incorporation assay, or by BrdU incorporation followed by FACS 
analysis using a fluorescent in situ cell proliferation kit (Roche Diagnostics, Mannheim, 
Germany) The following antibodies were used for immunophenotyping: anti-CD19 (mAb 
clone 6D5, Abcam, Cambridge, UK), anti-B220 (mAb clone RA3-6B2, BD Pharmingen), 
anti-IgM (polyclonal goat, no. 1020, Southern Biotech, Birmingham, USA), anti-IgG 
(polyclonal goat, no. 1030, Southern Biotech), anti-CD3 (mAb clone 145-2C11, BD 
Pharmingen), anti-CD11c (mAb clone N418, AbD Serotec, Oxford, UK), anti-PCNA 
(mAb clone PC10, Zymed Labs, South San Francisco, USA) and anti-CD11b (mAb clone 
M1/70.15, AbD Serotec, Oxford, UK). Flow cytometry was performed on a CyanADP 
instrument (Dako, Glostrup, Denmark).  
 
Patient material  
Human patient material was obtained from seven patients with gastric MALT lymphoma 
that were part of a previously published study conducted at Philipps-University Marburg, 
Germany.24 All tumors were diagnosed as H. pylori-positive low grade gastric MALT 
lymphomas and all were negative for the translocation t(11;18)(q21:q21). The five cases 
of CLL, diagnosed according to standard criteria, were described in previous studies;25,26 
all five tumor-derived IgVH sequences had been determined previously to be somatically 
mutated. 
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RNA extraction, VH and VL gene amplification and cloning  
RNA was isolated from the murine tumor cell suspensions and from patient biopsy 
material using the RNeasy kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions. cDNA was synthesized using oligo-dT primers and SuperScript® III reverse 
transcriptase (Invitrogen, Carlsbad, CA). The human Ig heavy and light chain sequences 
were obtained using Ig framework-specific primers for all human variable heavy and 
light chain framework 1 families in combination with primers specific for all human J 
segments, as specified by Marks et al.27 The obtained variable heavy and light chain 
products were cloned into expression vectors in frame with a 5’ leader peptide and a 3’ 
human IgG1 or kappa light chain constant domain. The amplification and cloning of 
murine Ig variable heavy and light chain sequences was performed accordingly. 
 
Sequence analysis  
Sequencing of heavy and light chain variable regions was performed by Microsynth 
(Balgach, Switzerland). The obtained sequences were aligned to germline sequences from 
the IGMT database (international ImMunoGeneTics database, http://www.imgt.org). 
Tumors were defined as clonal if identical or near identical VH sequences were obtained 
from two independent PCR reactions. Somatic hypermutation and intraclonal variation of 
IgVH genes was assessed as described by Lossos et al.;28 VH gene sequences that deviated 
by more than 2% from the corresponding germline gene sequence were defined as 
somatically hypermutated. The degree of intraclonal diversity of IgVH genes was defined 
as follows: an unconfirmed mutation is a substitution mutation observed in only one of 
the VH gene clones from the same tumor specimen; a confirmed mutation is a mutation 
observed in more than one VH clone from the same tumor specimen.28 The role of antigen 
selection in shaping MALT lymphoma immunoglobulins was assessed by calculating and 
comparing the ratios of replacement (R) to silent (S) mutations in the framework (FR) 
and complementarity determining regions (CDR) of the somatically mutated Ig heavy 
chain genes. Positive selection was  diagnosed if the R/S ratios of mutations in the CDRs 
were greater than 2.9; negative selection pressure by antigen was postulated if the R/S 
ratios in the FR regions were lower than 2.9.29 The probability that an excess or scarcity 
of replacement mutations in VH complementary determining regions (CDRs) or 
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framework regions occurred by chance was calculated by a multinomial distribution 
model.30 A p-value < 0.05 was considered statistically significant. 
 
Expression and purification of recombinant antibodies 
293T cells were cultured in Opti-MEM I reduced Serum Media (Invitrogen) 
supplemented with GlutaMAX (Invitrogen). Cells were transfected by calcium phosphate 
co-precipitation with equimass amounts of the heavy and light chain vector and the 
supernatant was harvested after seven days. Recombinant antibodies were purified from 
culture supernatants on a 1 ml HiTrap Protein G Sepharose column (Amersham 
Pharmacia Biotech) and dialyzed against phosphate buffered saline (PBS). 
 
Preparation of H. felis antigens, murine stomach extract and AGS cell extract  
H. felis and H. pylori were grown as described.21 Sonicate was prepared by harvesting 
cells in PBS and the cells were disrupted by sonication (Bandelin Sonopuls GM 70, 
Bandelin, Berlin, Germany). For preparation of gastric mucosal extract, the mucosa was 
scraped from WT BALB/c mice and lysed in lysis buffer (10% glycerol, 1% Triton X-
100, 100 nM NaCl, 20 mM HEPES (pH 7.4) and 1 mM sodium vanadate). For 
preparation of human stomach cell extract, human gastric carcinoma cells (AGS) were 
lysed with the same buffer. The protein content of all antigen preparations was 
determined by BCA protein assay (Thermo Scientific, Rockford, USA) and aliquots were 
stored at -70oC until used.  
 
Enzyme linked immunosorbant assays 
Duplicate wells of Maxisorp micotiter plates (Nunc, Denmark) were coated with various 
antigens. Single stranded DNA (ssDNA) and double stranded DNA (dsDNA) were 
coated at 100μg/ml in PBS. All other antigens tested were coated at 5μg/ml each in PBS. 
After washing with PBS-0.5% (v/v) Tween 20 the wells were blocked with 2% BSA in 
PBS for 2 hours. All antibodies were incubated o/n at 0.1, 1 and 10 μg/ml at 4oC.  After 
washing, wells were incubated for 1 hour with either peroxidase-conjugated goat anti-
mouse IgG (Jackson ImmunoResearch Laboratories) or goat peroxidase-conjugated anti-
human IgG (Abcam). Enzyme activity was detected by incubation with 
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 8 
tetramethylbenzidine (TMB; Sigma-Aldrich). Rheumatoid factor (RF) activity of murine  
and human antibodies was determined using the mouse RF Ig ELISA kit (Alpha 
diagnostic international, San Antonio, Texas) and the Aeskulisa Human Rf-AGM kit 
(Aesku Diagnostics, Wendelsheim, Germany), respectively. The dissociation constants 
(Kd) were calculated according to Friguet et al. 31 
 
 
RESULTS  
 
Induction of Helicobacter-dependent gastric MALT lymphoma in a BALB/c mouse 
model and ex vivo culturing of tumor cell suspensions 
In order to induce the formation of Helicobacter-dependent gastric MALT lymphoma, 18 
female BALB/c mice were infected with H. felis for 18 months; seven additional age-
matched females served as uninfected controls. 16 of the 18 infected, but none of the 
uninfected mice had developed gastric MALT lymphoma at the time of sacrifice. The 
tumors were macroscopically visible as nodules ranging from 1-2mm in diameter. They 
were positive for the B-cell marker B220 and had proliferative indices of ~30% as 
determined by PCNA staining (Figure 1A,B). The tumors had formed predominantly at 
the forestomach/corpus junction. A total of 20 macroscopically discernible tumors were 
dissected and single cell suspensions were generated of individual tumors. These were 
subjected to Ig sequence analysis (all 20 tumors; isolated from 10 individual mice), 
immunophenotyping (a subset of 14 tumors, from the same 10 mice) and/or ex vivo 
culturing (9 tumors from 8 mice). 
In the tumor cell suspension cultures, an average of 64% of all leukocytes were CD19+ B-
cells (Figure 1C); most of the remaining leukocytes stained positive for CD3 (Figure 1C). 
Only a minor fraction was positive for CD11b or CD11c (1.5% on average, data not 
shown). The suspensions generally contained fewer than 15% non-leukocyte cells. While 
all tumor cell suspensions could be kept alive for 5 days in standard cell culture media, 
only cultures to which Helicobacter lysate had been added proliferated within this time 
frame, as determined by [3H]-thymidine (Figure 1D) or BrdU incorporation (Figure 1E). 
Addition of Helicobacter lysate induced an on average 4 fold increase in [3H]-thymidine 
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 9 
incorporation compared to the corresponding unstimulated culture (Figure 1D); BrdU-
positive cells increased from ~2.5% in unstimulated cultures to ~3.8% in stimulated 
cultures (Figure 1E). Immunophenotyping of BrdU-positive cells further revealed that the 
proliferating population in the cultures consisted predominantly of CD19+ B-cells 
(average: 83%; Figure 1F), with T-cells accounting for the remaining proliferative subset. 
In conclusion, murine MALT lymphoma B-cells are not only antigen-dependent in vivo 
as we and others have shown previously by inducing tumor regression through 
Helicobacter eradication therapy,10,22 but also retain their dependence on Helicobacter 
antigen ex vivo.  
 
Immunophenotyping of murine MALT lymphomas 
Human MALT lymphomas are known to express surface IgM and pan-B-cell markers 
(CD19, CD20, CD79a) and the marginal zone markers CD35 and CD21, while being 
negative for CD5, CD10, CD23 and cyclin D1.32 Since we aimed to analyze the antibody 
sequences and specificity of our murine tumors, we flow cytometrically determined the 
surface IgM and IgG expression of 14 tumor cell suspensions (Figure 2). Indeed, the 
majority of CD19+, B220+ B-cells in every tumor showed high expression of IgM 
(average: 90%); a minority expressed high IgG (average: 1.5%) and the rest expressed 
only low levels of either Ig (Figure 2). 
 
Sequence analysis of murine MALT lymphoma immunoglobulins  
In order to determine the clonal status of a panel of 20 murine MALT lymphomas, the 
corresponding cDNAs were generated and subjected to several rounds of cloning and 
sequencing of the IgVH genes5. Tumors were pronounced monoclonal if more than half of 
all obtained IgVH sequences were identical or near identical in two independent rounds of 
sequencing. Clear monoclonal status was demonstrated for 11 lymphomas (55% of cases) 
whereas one lymphoma appeared biclonal and the remaining eight tumors were classified 
as polyclonal. None of the monoclonal sequences harbored internal stop codons, 
                                                
5
 All sequences reported in this paper have been deposited in the GenBank database 
(accession nos. GQ856044-GQ856073). 
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suggesting that murine MALT lymphoma B-cells express potentially functional surface 
IgM.   
The 11 clonal IgVH sequences were further analyzed for evidence of somatic 
hypermutation and intraclonal variation (Table 1). Germline genes with the highest 
homology to the consensus tumor IgVH sequence were identified (Supplemental Figure 
1); with the exception of two cases, all IgVH genes analyzed displayed somatic mutation, 
i.e. they deviated from the most closely related germline sequence in more than 2% of 
positions, with the average homology being 92.2% (Table 1, Supplemental Figure 1). 
This result is in line with previous studies reporting somatic hypermutation of human 
MALT lymphoma IgVH.14-16 Four IgVH sequences were found to be positively selected 
by antigen, i.e. the ratios of replacement/silent mutations in their CDRs were higher than 
would be expected if mutations had occurred by chance alone without selective forces 
(based on a cutoff ratio of >2.9;29 Table 1). Six sequences demonstrated the presence of 
negative selection pressure by antigen, i.e. the replacement/silent mutation ratios in their 
FR regions were lower than expected by chance alone. Two sequences showed evidence 
of both negative and positive selection. Analysis of antigen selection using the more 
stringent multinomial model28,30 identified only three sequences with significant positive 
selection and one with significant negative selection (Table 1). Previous studies 
examining antigenic selection of human IgVH have mostly reported evidence of positive 
selective pressure,14-16 suggesting that MALT lymphoma B-cells have undergone 
germinal center reactions and affinity maturation.  
To evaluate the presence of ongoing mutation, the 11 clonal sequences were examined by 
comparing at least 8 and up to 22 molecular clones from each tumor (Supplemental 
Figure 2). Five of the somatically mutated clonal VH gene isolates did not show 
intraclonal heterogeneity (Table 1), whereas the remaining six tumors, including the two 
with unmutated IgVH sequences, harbored confirmed mutations and therefore showed 
evidence of intraclonal variation (Table 1, Supplemental Figure 2). The average length of 
the CDR3 region for the 11 monoclonal tumor immunoglobulins was 12.5 amino acids, 
which is longer than the average length of 8.5 amino acids usually found in a normal 
murine splenic B-cell repertoire (Table 1).33 VH gene family use was found to be strongly 
biased towards VH1 (n=7) and VH14 (n=4). Of the 12 known murine VH gene families, 
 For personal use only. at UNIVERSITAETSSPITAL on January 14, 2010. www.bloodjournal.orgFrom 
                                                   
   
 
 11
the VH1 gene family accounts for 28% of the antibody repertoire in BALB/c splenocytes; 
the VH14 family in contrast is rarely used in BALB/c mice.   
 
Antigen reactivity of recombinant murine MALT lymphoma-derived antibodies  
To investigate the antigen specificity of murine MALT lymphoma Ig, the corresponding 
light chains of five of the clonal heavy chains were identified. In cases with ongoing 
mutation, the IgVH sequence most closely matching the consensus sequence was chosen. 
Paired heavy and light chains were expressed recombinantly in 293T cells and purified 
by affinity chromatography. We deliberately selected a mixed panel of mutated and 
unmutated, antigen selected and unselected IgVH sequences (mu Abs 2, 3 8, 10 and 11). 
A series of ELISA assays was used to systematically screen Ig reactivity towards a broad 
range of antigens. Possible autoreactivity was assessed using murine stomach extract; 
antinuclear activity was examined using both ssDNA and dsDNA, and rheumatoid factor 
activity was assessed by IgG binding; the foreign antigens tested included H. felis and E. 
coli sonicate and purified E. coli LPS. BSA was used as a negative control. The 
combined results of all ELISAs revealed quite unequivocally that all antibodies analyzed 
bound to a surprising variety of antigens in a dose-dependant manner (Figure 3). An 
overall trend of higher affinity binding towards more complex antigen compositions 
(extracts of H. felis and of murine stomach) was noted; no preference for either 
Helicobacter-only reactivity or autoreactivity-only could be detected in any of the 
antibodies’ ELISA profiles. A monoclonal, isotype-matched murine control antibody 
failed to bind any of the antigens tested (Figure 3). Somatically mutated antibodies did 
not differ from unmutated antibodies, and evidence of antigen selection in the IgVH 
sequence also did not seem to correlate with an increased overall or antigen-specific 
affinity.
 
 
Taken together, our results support a diagnosis of polyreactivity. To confirm the 
specificity of the assay, we performed a series of competitive inhibition ELISAs (Figure 
4A-C). To this end, binding of the antibody of interest to one of its targets (immobilized 
on the ELISA plate) was competitively blocked with increasing concentrations of soluble 
target of the same or an alternative specificity. In all combinations tested, the soluble 
phase antigens were able to competitively block binding to the immobilized target in a 
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dose-dependent manner (Figure 4A-C). As would be expected, high affinity soluble 
antigens blocked binding to low affinity immobilized targets with a higher efficiency than 
vice versa (Figure 4A-C). BSA, which was used as a negative control, did not block 
binding even at 100x excess (Figure 4A,B). Overall, the competition results confirmed 
the specificity of the ELISA assays as well as our general observation that complex 
antigen mixtures constitute higher affinity targets than relatively simple structures such as 
DNA or LPS.  
 
Sequence analysis of human MALT lymphoma immunoglobulins  
In order to be able to compare the sequence characteristics and specificity of the murine 
tumor immunoglobulins to their human counterparts, we cloned, sequenced and 
recombinantly expressed the antibodies of seven human low grade MALT lymphomas.24 
All seven cases were clonal. Five of the seven cases showed evidence of somatic 
hypermutation (Table 2, Supplemental Figure 3). Interestingly, we found a bias towards 
use of the VH gene segment 1-69*01, which was used in four of the seven cases (Table 
2), and has been reported previously for MALT lymphomas of the parotid gland, stomach 
and lung.13 No bias was detected in J and D segment use, but all matching light chains 
were of the κ isotype (Table 2), another seemingly common bias in MALT lymphoma 
antibodies.13,20 Three out of seven cases further showed evidence of intraclonal variation 
(Table 2, Supplemental Figure 4). Interestingly, the CDR3 length of the heavy chains was 
higher than average (15.3 amino acids as opposed to the 12.7 amino acids usually found 
in human blood B-cell antibodies)33 confirming our observation from the murine model. 
Overall, the sequence analysis of our panel of seven antibodies confirmed several 
observations reported previously for human gastric MALT lymphoma and the panel was 
therefore considered suitable for antigen binding studies. 
 
Antigen reactivity of recombinant human MALT lymphoma-derived antibodies  
In order to determine if human MALT lymphoma Ig also follows a polyspecific binding 
pattern, matched heavy and light chains of all seven human MALT lymphoma cases were 
screened for reactivity towards BSA, H. pylori sonicate, LPS, IgG, ssDNA and AGS cell 
extract (Figure 5A).  All but one (hu Ab2) of the human MALT lymphoma antibodies 
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exhibited a polyreactive binding profile very similar to the patterns observed with the 
murine tumor Igs. Interestingly, hu Ab2 was the only human tumor antibody on the panel 
to not have undergone either somatic hypermutation or ongoing mutation. As observed 
for the murine polyreactive MALT lymphoma antibodies, a trend of higher affinity 
binding towards more complex antigen compositions was evident (Figure 5A). To 
properly control for the validity of our ELISA readout in the human system, we chose 
five additional non-MALT lymphomas for amplification of their immunoglobulin genes, 
sequence analysis and recombinant expression in 293T cells and subsequent ELISA 
analysis. We selected cases of “mutated” chronic lymphocytic leukemia (CLL; i.e. cases 
expressing somatically mutated Ig), as these are known to be monoreactive in contrast to 
their “unmutated” CLL counterparts.34 All five cases were clonal and showed on average 
93% homology with the most closely related germline sequence. None of the antibodies 
displayed a polyreactive binding pattern similar to the one we observed for 6 out of the 7 
MALT lymphoma Igs. In fact, all but one of the five CLL antibodies failed to show any 
affinity for any of the targets of our ELISAs (one -Ab3- bound to ssDNA, but not to any 
of the other antigens). This result showed that MALT lymphoma antibodies have 
fundamentally different antigen-binding properties than monoreactive CLL antibodies, 
and confirms the validity of our ELISA assay.  
Finally, the antigen specificity of the recombinant human MALT lymphoma antibodies 
was confirmed by a series of competitive inhibition ELISAs (Figure 6A-C); as observed 
for the murine antibodies, soluble phase antigens were able to competitively block 
binding to the immobilized target in a dose-dependent manner, whereas BSA did not 
block binding even at 100x excess (Figure 6A-C).  
In order to assess the binding affinity of the various tumor Igs, we calculated KD values 
for a select group of 6 tumor antibody-antigen complexes using a curve-fitting approach 
as described.31 The KD values ranged from 1.1x10-7 M (hu Ab5 reactivity towards LPS) to 
6.3x10-8 M (hu Ab4 towards H. pylori extract). Murine tumor antibodies showed a similar 
range of affinity (e.g. KD=2x10-8 M for mu Ab11 towards ssDNA; KD=5x10-8 M for mu 
Ab11 towards stomach extract). Overall, the binding affinity of polyspecific MALT 
lymphoma derived antibodies is clearly lower than what is typically observed for 
monoreactive antibodies (which have KDs of 10-8-10-11 M), but higher than the typical 
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affinity of polyreactive, unmutated IgM expressed by immature B-cells (KDs of 10-4-10-7 
M).35 
 
 
DISCUSSION  
 
Persistent infection of BALB/c mice with various Helicobacter species results in the 
development of gastric MALT lymphoma in a majority of mice, with “clinical” features 
that are strikingly similar to the human form of the malignancy: late onset of disease, 
dependence on active infection with the organisms, and a low propensity for spreading. 
10,21-23
 We show here that several molecular parameters of the murine tumors also mimic 
the human disease well: (1) the monoclonal status of over half of all individually 
dissected tumors, (2) the antigen dependence of tumor cell proliferation in vitro, (3) the 
surface exposure of IgM and apparent lack of class switch recombination, (4) the somatic 
hypermutation of antibody sequences, accompanied in several cases by positive and/or 
negative antigen selection, and (5) the intraclonal variability that is a hallmark of 
continuing antigen exposure and consequently, ongoing somatic mutation. We further 
demonstrate that both the murine tumor-derived antibodies as well as all but one of the 
antibodies derived from MALT lymphoma patient biopsies show a pattern of 
polyreactivity, displaying equally strong affinity towards a diverse panel of foreign but 
also self-antigens. Finally, this result is corroborated by our observation of a strong bias 
towards the use of VH gene segments that have previously been associated with auto- or 
polyreactive antibodies in other B-cell malignancies or autoimmune pathologies.  
In the murine setting, we often find that more than one tumor arises per stomach, i.e. the 
lymphoma presents as a multifocal disease (as is the case in humans).36 In those cases in 
which we were able to dissect multiple monoclonal tumors from the same stomach, they 
were usually derived from independent clones, confirming that MALT lymphoma is a 
highly localized disease with little tendency to spread, even within the same organ. The 
monoclonal status of 55% of individually dissected tumors confirms the validity of our 
model; clonality rates of human MALT lymphomas range from 63 to 92% of 
histologically confirmed cases.20,37 The lower rates of clonality in the murine model may 
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be due to the tiny size and multifocal nature of the murine tumors, which are difficult to 
dissect without contamination from surrounding normal tissue as well as neighboring 
tumor material.  
Gastric MALT lymphomas are antigen-dependent in their early stages, i.e. they require 
the constant presence of as yet unknown antigen(s) for growth in vivo.9,10,22 Interestingly, 
this requirement for antigen is retained in ex vivo cultures of single cell suspensions 
derived from individual murine tumors, which proliferate only in the presence of 
Helicobacter extract. Despite the apparent complexity of tumor cell suspensions, which 
contained a significant proportion of admixed T-cells and other leukocytes, the 
proliferating population consisted predominantly of (tumor) B-cells. 
The immunoglobulin genes of murine as well as human gastric MALT lymphomas are 
subject to somatic hypermutation but fail to undergo class switch recombination. Indeed, 
expression of the enzyme responsible for both processes, activation-induced cytidine 
deaminase (AID), could be detected by RT-PCR both in generated from murine tumor 
material and from the human MALT lymphomas (data not shown). Although the two 
processes are known to be linked and usually happen simultaneously during germinal 
center reactions, it is now widely accepted that a fraction of post-germinal center memory 
cells are IgM+.38 In particular, this seeming contradiction has been described multiple 
times in B-cell malignancies such as Burkitt’s lymphoma and CLL as well as in 
extracerebral and CNS DLBCL.39,40 In MALT lymphoma, switch recombination is often 
“illegitimate”, i.e. involving only one rather than two switch sites and leading to an 
aberrant rearrangement of the IgH switch region not actually accompanied by isotope 
switching.40 The fact that the IgVH genes of both our panels of murine and human tumor 
antibodies are somatically hypermutated and, at least in ~50% of cases, are subject to 
ongoing mutation suggest that antigen plays a role during the initiation and the 
progression of the tumor.  
In order to examine the reactivity of five murine and seven human tumor 
immunoglobulins with various auto- and foreign antigens, we recombinantly expressed 
them as murine and human IgG, respectively; this approach ensured that the specificity of 
the recombinant antibodies indeed corresponded with that of the tumor while maintaining 
sufficiently high avidity. Previous efforts with the exception of one report20 have 
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identified a multitude of alternative targets with the shared characteristic of being auto-
antigens.41,19,18 For example, Bende et al. found that seven out of ten gastric and non-
gastric MALT lymphoma antibodies had rheumatoid factor activity, i.e. they bound to 
auto-IgG.13 
Our study confirms binding of MALT lymphoma antibodies to IgG. However, with 
roughly the same or an even higher affinity, our panel of antibodies also bound to a 
variety of other targets, including Helicobacter-derived antigens and stomach extract. 
The reactivity was nevertheless “specific” in the sense that binding could be blocked to a 
solid-phase target by an excess of an alternative, soluble target in a concentration-
dependent manner. The prevalence of polyreactivity in our panel of antibodies is clearly 
higher than that of normal peripheral mature B-cells, in which the polyreactivity rate is 
estimated to be under 5%.42 
Polyreactivity is not a new phenomenon in the context of B-cell malignancies. It has been 
described in detail for CLL, which, like MALT lymphoma, is believed to be an antigen-
driven malignancy. A majority of unmutated, but not of mutated CLL-derived antibodies 
tested with respect to their specificity have revealed polyreactive patterns in previous 
studies, binding to DNA, IgG, insulin and LPS.34,43 In contrast, mutated CLL-derived 
antibodies are typically monoreactive.34,43 Indeed, none of the mutated five CLL 
antibodies we included as controls in our analysis showed evidence of polyreactivity. 
With respect to the link between mutational status and antigen reactivity, CLL-derived 
antibodies thus differ clearly from MALT lymphoma-derived antibodies. In fact, we 
found that the only human MALT lymphoma Ig that failed to exhibit polyreactivity was 
also the only unmutated antibody among those analyzed. It will be interesting to see 
whether the link between mutation status and polyreactive binding profile holds true in 
larger studies that include more of the rare unmutated cases. 
Both polyreactive CLL44 and the MALT tumor immunoglobulins reported here share a 
strongly biased use of the IgVH1-69 gene segment; four out of seven of our panel of 
human MALT lymphoma antibodies use this segment and of these, three combine the 
IgVH1-69 heavy chain with the same light chain VL segment IGKV3-20*01. This exact 
combination is typical of rheumatoid factors, with IgVH1-69 being preferentially used in 
autoimmune gammopathies reactive towards human IgG such as cryoglobulinemia and 
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Waldenstrom’s macroglobulinemia.45,46 IgVH1-69 was also found to be used in a biased 
fashion in non-gastric MALT lymphomas including those of the parotid gland, tonsil and 
lung.13 Overall, the strongly biased use of IgVH1-69 in MALT lymphoma and CLL is 
consistent with their shared polyreactive antibody specificity, as well as their shared 
dependence on antigenic stimulation.   
Polyreactivity is thought to be caused by a special flexibility of the antigen-binding 
pocket, with multiple configurations or “isomers” of an antibody existing even before 
exposure to antigen;47,48 some evidence suggests that a longer CDR3 region of 
polyreactive antibodies might be underlying this flexibility.49 Indeed, we find that our 
human as well as our mouse MALT lymphoma antibodies possess longer than average 
CDR3 regions. In conclusion, many of the known molecular and structural hallmarks of 
polyreactive antibodies such as IgM class, CDR3 length and preferential VH gene use are 
detected in MALT lymphoma antibodies and are consistent with our experimental finding 
of polyreactivity, suggesting a role for antigenic stimulation in MALT lymphoma 
pathogenesis. 
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FIGURE LEGENDS 
 
Figure 1: Murine MALT lymphoma cells proliferate in response to Helicobacter 
antigen. (A, B) Histopathology of murine MALT lymphoma. Consecutive paraffin 
sections were stained with H&E, the B-cell marker B220 and the proliferation marker 
PCNA; representative sections are shown for an unaffected area (A) and a lymphoma (B) 
from the same stomach. (C-F) Single cell suspensions of nine murine MALT lymphomas 
were cultured in the presence or absence of 10μg/ml Helicobacter felis lysate. The 
proportion of CD19+ B-cells and CD3+ T-cells was determined flow cytometrically for 
every culture (C). Proliferation was determined by [3H]-thymidine incorporation (D) or 
BrdU incorporation (E) after five days of culturing. Individual cultures and/or averages of 
all cultures are shown. (F) The BrdU+ cells are mostly B- and T-cells.  
 
Figure 2. Murine MALT lymphoma cells express B220 and CD19 and are surface 
IgM positive. 
14 independent single cell suspension cultures of murine MALT lymphomas were 
analyzed flow cytometrically with respect to B220, CD19 and IgM/IgG expression. 
Results from a representative culture as well as the averages of all 14 cultures are shown. 
 
Figure 3. Recombinant murine MALT lymphoma-derived antibodies are 
polyreactive. 
Three concentrations (0.1, 1 and 10μg/ml) of five murine antibodies cloned from the 
tumors of five independent mice and recombinantly expressed in 293T cells were tested 
by ELISA for reactivity towards BSA, LPS, IgG, dsDNA, ssDNA, E. coli or H. felis 
sonicate and protein extracted from the mucosa of BALB/c stomachs (either infected with 
H. felis or uninfected). Antibodies 2, 3, 8 and 11 display strong reactivity towards the 
majority of targets whereas Ab10 has comparatively low affinity. A monoreactive 
antibody (mu AbGR1) was used as a control.  
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Figure 4. Competitive inhibition ELISAs confirm polyreactive binding patterns of 
murine MALT lymphoma antibodies. (A-C) A single concentration of the indicated 
recombinant murine antibodies 3, 11 and 10 (10μg/ml) was incubated with plate-coated 
(solid-phase) antigen in the presence of a 10x excess of the same antigen in soluble form 
or increasing concentrations of an alternative soluble antigen. Three representative 
inhibition assays are shown and demonstrate the ability of different soluble phase 
antigens to inhibit the binding of the antibody to solid phase antigens. In contrast, BSA 
did not block binding of Abs 3 and 11 even at 100x excess concentrations (right panels in 
A and B).   
 
Figure 5. Recombinant human MALT lymphoma-derived antibodies are 
polyreactive.  
Three concentrations (0.1, 1 and 10μg/ml) of seven recombinant human MALT 
lymphoma antibodies (A) and five recombinant human CLL antibodies (B) were tested 
by ELISA for reactivity with the antigens indicated in the legends. All MALT lymphoma 
antibodies with the exception of Ab2, but none of the CLL antibodies, exhibit a 
polyreactive binding pattern. 
 
Figure 6. Competitive inhibition ELISAs confirm polyreactive binding patterns of 
human MALT lymphoma antibodies. (A-C) Three representative competition ELISAs 
performed as described in the legend to Figure 4 are shown and demonstrate the ability of 
different soluble targets to inhibit the binding of the recombinant antibody of interest (5, 
4, and 1; used at 10μg/ml) to solid phase antigens. BSA did not block binding of Abs 5 
and 4 even at 100x excess concentrations (right panels in A and B).   
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